id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-1143-0002,FDA,FDA-2013-D-1143,"Draft Guidance for Industry:  Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus From Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products",Other,Guidance,2013-10-24T04:00:00Z,2013,10,2013-10-24T04:00:00Z,,2024-11-12T05:20:29Z,,1,0,090000648145d7aa
FDA-2013-D-1143-0001,FDA,FDA-2013-D-1143,"Draft Guidance for Industry:  Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus From Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products; Availability",Notice,Notice of Availability,2013-10-24T04:00:00Z,2013,10,2013-10-24T04:00:00Z,2014-01-23T04:59:59Z,2014-03-28T01:01:32Z,2013-24940,0,0,090000648145d509